CLNN
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Clene submits a New Drug Application to the FDA for CNM-Au8 to treat ALSOct 19, 2026
- Clene announced that biomarker analyses will be included in its NDA submission supporting accelerated approval for ALSAug 10, 2026
- Clene prepared for accelerated NDA filing for ALS following a successful FDA meetingMay 4, 2026
- Clene announced statistically significant ALS biomarker results supporting accelerated approval pathway for CNM-Au8®Dec 3, 2025
- Clene presents new clinical data at ECTRIMS 2025 demonstrating CNM-Au8® improves brain energy metabolism in multiple sclerosis patientsSep 25, 2025